Roth Capital Initiates Celladon At Buy

Analysts at Roth Capital initiated coverage on Celladon Corporation CLDN with a Buy rating. Celladon shares have gained 70.15% over the past 52 weeks, while the S&P 500 index has surged 11.80% in the same period. Celladon's shares rose 10.69% to $21.75 in pre-market trading.